Get alerts on this situation
We’ll email you as it develops, and you can follow the whole thread from day one.
Unsubscribe anytime.
[SITUATION] · [ACTIVE]
2 clusters · 5 sources · 4 days · First seen · Last updated
Categories: HEALTH
UK ramipril shortage and supply cap
Entities: National Pharmacy Association · Department of Health and Social Care · Olivier Picard · Ramipril · United Kingdom
Overview
UK health authorities have kept a one‑month dispensing limit on the blood‑pressure drug ramipril in place until 30 October, extending an emergency restriction first introduced in April. The cap was originally imposed to curb stockpiling and manage supply‑chain disruptions linked to global manufacturing delays and the war in the Middle East.
Pharmacists in England and Scotland are urging regulators to allow broader substitution under Serious Shortage Protocols, arguing that the rigid limit creates administrative bottlenecks and anxiety for patients with chronic hypertension, heart failure or diabetic kidney disease. Clinical teams stress that patients should not alter dosing or ration medication, while the National Pharmacy Association calls for permission to dispense alternatives such as lisinopril without additional doctor approval.
The shortage now affects roughly six million patients in the United Kingdom, and the protocol bars pharmacists from substituting other treatments without a prescriber’s consent. Officials maintain the measures are necessary to stabilise the national supply chain while a longer‑term solution is pursued.
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 3 SOURCES] Ramipril is in critical supply in the United Kingdom, affecting about six million patients. (All three articles report the shortage and the number of patients.)
- [● 3 SOURCES] The Department of Health and Social Care placed ramipril under a serious shortage protocol limiting supply to one month until 30 October. (All three articles mention the protocol and its deadline.)
- [● 3 SOURCES] Pharmacists are unable to substitute ramipril without consulting a doctor. (All three articles state that pharmacists cannot prescribe alternatives without GP approval.)
- [● 3 SOURCES] The shortage is partly caused by disruptions to the global supply chain linked to the war in the Middle East. (All three articles mention the Middle East war as a factor in the shortage.)
- [● 3 SOURCES] In April the Department of Health and Social Care restricted 1.25 mg ramipril tablets to a maximum of 28 tablets per prescription. (All three articles refer to the April restriction on the 1.25 mg strength.)
- [● 3 SOURCES] Olivier Picard, chair of the National Pharmacy Association, urged the government to allow pharmacist substitutions for ramipril. (All three articles quote Picard making this request.)
- [● 3 SOURCES] Patients who receive fewer ramipril tablets than prescribed will not be charged for the medication. (All three articles note that reduced prescriptions are provided free of charge.)
Timeline
-
3 days ago
[HEALTH] 3 sourcesUK ramipril shortage triggers supply protocolUK faces a critical ramipril shortage affecting ~6 million patients; a serious shortage protocol limits supplies to one month until Oct 30 and blocks pharmacist substitutions.
-
7 days ago
[HEALTH] 2 sourcesUK extends emergency ramipril supply cap to Oct. 30UK health officials have extended the emergency one‑month ramipril dispensing limit to Oct. 30, as pharmacists seek substitution flexibility amid ongoing supply shortages.
Sources
ca.sports.yahoo.com · independent.co.uk · uk.news.yahoo.com · world-today-journal.com · world-today-news.com